MedCity News
NOVEMBER 24, 2024
One of the most important things providers can do on the journey toward consumer-driven care is to check their paternalism at the door, said Nworah Ayogu, head of healthcare impact at Thrive Capital. The post These 3 Mindset Shifts Will Help Providers Deliver Consumer-Driven Care, Investor Says appeared first on MedCity News.
Fierce Pharma
NOVEMBER 25, 2024
On a Zoom call last month from California, BridgeBio CEO Neil Kumar needled a colleague about the remote possibility of the New York Yankees rallying to win the World Series as they trailed the Los | The FDA has signed off on BridgeBio's Attruby (acoramidis), a potential blockbuster to treat patients with the rare heart disease transthyretin amyloid cardiomyopathy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
NOVEMBER 28, 2024
When the General Data Protection Regulation (GDPR) 1 came into effect in 2018, this appeared to accelerate the migration out of Europe for pharmaceutical clinical trials. This was not so much due to non-compliance but stemmed from regulatory ambiguity. As the EU now sets its sights on the regulation of artificial intelligence (AI) through the EU Artificial Intelligence Act (EU AI Act), 2 similar questions arise regarding the implementation and enforcement of the regulation.
PharmaVoice
NOVEMBER 26, 2024
Stoke Therapeutics is entering phase 3 with its RNA medicine designed to treat a rare epileptic condition.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
NOVEMBER 25, 2024
BridgeBio Pharma claims its drug, Attruby, has an edge over a Pfizer drug as a treatment for cardiomyopathy caused by transthyretin-mediated amyloidosis. But new competition to both products could come soon from Alnylam Pharmaceuticals, now set to receive an FDA decision in this indication by late March. The post FDA Nod for BridgeBio Brings New Competition to Blockbuster Pfizer Cardio Drug appeared first on MedCity News.
Fierce Pharma
NOVEMBER 26, 2024
German CDMO Adragos Pharma has been on a growth tear this year, drafting plans to boost capacity in Japan, upgrading a facility in France, taking over another from Fresenius Kabi in Norway and more | German CDMO Adragos Pharma has been on a growth tear this year. Now, the manufacturing arriviste—which was founded in 2020—is expanding its production network again with the acquisition of Switzerland's Baccinex, which specializes in fill and finish services.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
NOVEMBER 26, 2024
Pharma companies looking to get a break from the FTC under a new administration may be out of luck.
MedCity News
NOVEMBER 26, 2024
Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for cancers and immunological indications. The two companies have been partners in hematological malignancies since 2022. The post Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition appeared first on MedCity News.
Fierce Pharma
NOVEMBER 26, 2024
While Novartis has largely wrapped up its transformation into a leaner innovative medicines company—which included multiple rounds of staff cuts over the years—employment changes are still afoot at | Novartis is laying off a total of 139 staffers in East Hanover, New Jersey, where the company’s U.S. headquarters is located. The move will primarily affect commercial field sales associates working on the brands Xolair for asthma and allergies and the oncology combo made up of kinase inhibitors Taf
European Pharmaceutical Review
NOVEMBER 29, 2024
A novel, environmentally-friendly method has been developed for simultaneous quantification a complex anti-migraine formulation using UV spectroscopy and chemometric models. The paper highlighted that “sustainable, cost-effective, and environmentally conscious practices in pharmaceutical analysis has become a paramount imperative”. The researchers continued to explain that while a novel fixed-dose anti-migraine formulation of ergotamine (ERG), propyphenazone (PRO), caffeine (CAF), camylofin (CAM
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Pharma Marketing Network
NOVEMBER 24, 2024
Table of Contents Sr# Headings 1 Introduction: Why Healthcare Marketing Matters 2 Understanding the Pharma Market Landscape 3 Targeting Healthcare Professionals (HCPs) 4 The Power of Patient-Centric Marketing 5 Digital Marketing: A Game-Changer for Pharma 6 Leveraging AI in Healthcare Marketing 7 Crafting Compelling Content Strategies 8 Navigating Regulatory Compliance 9 Harnessing Data Analytics for Better Campaigns 10 Influencer Marketing in the Healthcare Space 11 Why Social Media is Vital fo
MedCity News
NOVEMBER 26, 2024
In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company. She discusses the funding the company recently received through the Sprint for Women’s Health program. The post MedCity FemFwd: How Celmatix is Using ARPA-H’s Sprint for Women’s Health Funding appeared first on MedCity News.
Fierce Pharma
NOVEMBER 27, 2024
On a routine basis in recent years, headlines about layoffs in the biopharma industry have surfaced as companies large and small have been cutting costs and restructuring. | A survey of life sciences CEOs found that 94% plan to grow their workforce over the next three years, with 37% envisioning that the head count of their company will grow by at least 6%.
European Pharmaceutical Review
NOVEMBER 27, 2024
Researchers have developed a novel, cost-effective bacterial system for production of fully endotoxin-free recombinant proteins. Lipopolysaccharides (LPS)-deficient Acinetobacter baumannii was used for the purification of recombinant proteins. Positively, conducting an assay test demonstrated an ability to suppress viral infection. The team shared in their paper that there is “ample scope for enhancing the yield of recombinant proteins” yet currently, this is lower than that of existing E. coli
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Eversana Intouch
NOVEMBER 26, 2024
The Current Landscape: AI’s Transformative Impact on Healthcare Marketing The healthcare marketing industry is at the forefront of a significant transformation, driven by advances in artificial intelligence (AI). Today, generative AI applications – particularly large language models (LLMs) and image-generation tools – are streamlining labor-intensive tasks such as research, documentation, content editing and concept ideation.
MedCity News
NOVEMBER 26, 2024
Amgen’s experimental obesity drug, MariTide, led to an average 20% reduction in weight in a Phase 2 clinical trial. While investors hoped for greater weight loss, some analysts say less burdensome monthly dosing of MariTide could make it competitive against weekly injectable weight drugs Zepbound and Wegovy. The post Weight Loss With Amgen Drug in Line With Eli Lilly Med, But Dosing Could Be Differentiator appeared first on MedCity News.
Fierce Pharma
NOVEMBER 25, 2024
After a recent failed showing in a breast cancer subgroup raised doubts around AstraZeneca’s Truqap, the first-in-class AKT inhibitor is making inroads in a prostate cancer subtype. | The AKT inhibitor's early win in a prostate cancer subtype follows a recent surprise flop in a breast cancer study. AZ has been working to grow Truqap beyond its current limited approval in a niche breast cancer category.
European Pharmaceutical Review
NOVEMBER 25, 2024
The pharmaceutical analytical testing market is seeing significant growth following a greater incidence in the complexity of medicine development and higher demand for biologics and biosimilars, according to a report by Straits Research Pvt. Ltd. Their analysis projected that the market will exceed a value of $15.46 billion by 2032. The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 percent between 2024 and 2032.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Contrarian Sales Techniques
NOVEMBER 27, 2024
Selling pharmaceuticals isn’t just about pushing a single product anymore. Especially in Malaysia, where healthcare needs are diverse, success often comes down to how well you can offer solutions that truly make a difference. That’s where portfolio selling comes in. Instead of focusing on one product at a time, this approach helps pharma reps present a range of options that work together.
MedCity News
NOVEMBER 26, 2024
While advanced analytics and AI can unlock unprecedented insights, it’s the thoughtful application of these insights that transforms routine interactions between pharmaceutical representatives and healthcare providers into lasting relationships. The post AI-Powered Insights for Personalized Customer Experiences: The Art of Data-Driven Engagement appeared first on MedCity News.
Fierce Pharma
NOVEMBER 25, 2024
Bristol Myers Squibb has executed another round of layoffs in its ongoing cost-savings push. | Bristol Myers Squibb has executed another round of layoffs in its ongoing cost-savings push. The company has handed pink slips to 195 more employees, according to a New Jersey Worker Adjustment and Retraining Notification (WARN) update.
Pharma IQ
NOVEMBER 28, 2024
Explore strategies for DSCSA compliance with insights from Aladdin Mandishah, Director of Product Marketing at SAP.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaVoice
NOVEMBER 27, 2024
Lindus Health’s women-focused CRO is the latest in a handful of research efforts to target specialized — and underrepresented — populations.
MedCity News
NOVEMBER 24, 2024
Halozyme views its drug delivery technology for biologic medicines as complementary to Evotec’s biologic drug manufacturing capabilities. But according to Halozyme, Evotec was unwilling to engage in any merger discussions. The post Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy appeared first on MedCity News.
Fierce Pharma
NOVEMBER 27, 2024
The competition among three TROP2 antibody-drug conjugates is ent | The competition among three TROP2 antibody-drug conjugates is entering a new stage as Kelun-Biotech’s Merck & Co.-partnered sacituzumab tirumotecan has become the second therapy in the class to win a marketing approval.
Pharmaceutical Technology
NOVEMBER 27, 2024
Pharmaceutical professionals expect digital solutions to solve drug development headaches, with AI already proving disruptive.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
NOVEMBER 26, 2024
Outgoing US President Joe Biden has proposed a dramatic expansion of Medicare coverage of obesity drugs, but will the plan see the light of day?
MedCity News
NOVEMBER 26, 2024
Pricy GLP-1 medications are here to stay — let’s focus on turning their potential into lasting, meaningful impact. The post The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care appeared first on MedCity News.
Fierce Pharma
NOVEMBER 26, 2024
In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “am | Shorla Oncology has scored an FDA approval for its strawberry-flavored drink version of Novartis' cancer drug Gleevec. Dubbed Imkeldi, it becomes the first oral liquid form of imatinib.
PharmaTimes
NOVEMBER 28, 2024
Therapy for autoimmune disorder shows potential
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Expert insights. Personalized for you.
317 
Let's personalize your content